Regulatory News: NANOBIOTIX (Paris:NANO) (Euronext: NANO ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced that ...
Original Article: NANOBIOTIX Selected to Enter Euronext's Tech 40 Label